304 related articles for article (PubMed ID: 17161566)
1. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV
Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
Manjunath K; Venkateswarlu V
J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399
[TBL] [Abstract][Full Text] [Related]
3. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of nitrendipine solid lipid nanoparticles.
Manjunath K; Venkateswarlu V; Hussain A
Pharmazie; 2011 Mar; 66(3):178-86. PubMed ID: 21553647
[TBL] [Abstract][Full Text] [Related]
5. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
[TBL] [Abstract][Full Text] [Related]
6. Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization.
Bhaskar K; Krishna Mohan C; Lingam M; Prabhakar Reddy V; Venkateswarlu V; Madhusudan Rao Y
Drug Dev Ind Pharm; 2008 Jul; 34(7):719-25. PubMed ID: 18612912
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
8. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F
Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846
[TBL] [Abstract][Full Text] [Related]
9. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
Thirupathi G; Swetha E; Narendar D
Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
[TBL] [Abstract][Full Text] [Related]
10. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
11. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.
Xia D; Cui F; Piao H; Cun D; Piao H; Jiang Y; Ouyang M; Quan P
Pharm Res; 2010 Sep; 27(9):1965-76. PubMed ID: 20585842
[TBL] [Abstract][Full Text] [Related]
12. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
13. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
14. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
[TBL] [Abstract][Full Text] [Related]
15. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
17. Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.
Quan P; Xia D; Piao H; Piao H; Shi K; Jia Y; Cui F
AAPS PharmSciTech; 2011 Dec; 12(4):1136-43. PubMed ID: 21892695
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
19. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
[TBL] [Abstract][Full Text] [Related]
20. Comparison of wax and glyceride solid lipid nanoparticles (SLN).
Jenning V; Gohla S
Int J Pharm; 2000 Mar; 196(2):219-22. PubMed ID: 10699722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]